Evidence map›Paper›PMID 20146387›Full record

Trial reportPediatric pulmonology2010

Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis.

Marci K Sontag, Alexandra L Quittner, Avani C Modi, Joni M Koenig, Don Giles, Christopher M Oermann, Michael W Konstan, Robert Castile, Frank J Accurso, Investigators and Coordinators of the Airway Secretion Clearance Trial

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Pediatric pulmonology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Active cycle of breathing technique for cystic fibrosis.The Cochrane database of systematic reviews · 2023
    Pooled it
  4. Oscillating devices for airway clearance in people with cystic fibrosis.The Cochrane database of systematic reviews · 2020
    Pooled it
  5. Oscillating devices for airway clearance in people with cystic fibrosis.The Cochrane database of systematic reviews · 2017
    Pooled it
  6. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis.The Cochrane database of systematic reviews · 2015
    Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Personalising airway clearance in chronic lung disease.European respiratory review : an official journal of the European Respiratory Society · 2017
    Review
  15. Clinician's Commentary on Morgan et al.(1).Physiotherapy Canada. Physiotherapie Canada · 2015
    Article
  16. Article
  17. Article
  18. Structure and function of the mucus clearance system of the lung.Cold Spring Harbor perspectives in medicine · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marci K SontagDepartment of Epidemiology, Colorado School of Public Health, University of Colorado Denver, 13001 E 17th, Box B119, Aurora, CO 80045, USA. marci.sontag@ucdenver.edu
Alexandra L Quittner
Avani C Modi
Joni M Koenig
Don Giles
Christopher M Oermann
Michael W Konstan
Robert Castile
Frank J Accurso
Investigators and Coordinators of the Airway Secretion Clearance Trial

Funding

Translational Research in Cystic FibrosisP30DK027651 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI DRUMM, MITCHELL L · 1986 to 2014
$15.6M
NIDDK NIH HHS P30 DK027651
6 · The paper itself

Abstract

rationaleAirway secretion clearance therapies are a cornerstone of cystic fibrosis care, however longitudinal comparative studies are rare. Our objectives were to compare three therapies [postural drainage and percussion: (postural drainage), flutter device (FD), and high frequency chest wall oscillation: (vest)], by studying (1) change in pulmonary function; (2) time to need for intravenous (IV) antibiotics, (3) use of pulmonary therapies, (4) adherence to treatment, (5) treatment satisfaction, and (6) quality of life.

methodsParticipants were randomly assigned to one of three therapies twice daily. Clinical outcomes were assessed quarterly over 3 years.

resultsEnrollment goals were not met, and withdrawal rates were high, especially in postural drainage (51%) and FD (26%), compared to vest (9%), resulting in early termination. FEV(1) decline, time to need IV antibiotics, and other pulmonary therapies were not different. The annual FEF(25-75%) predicted rate of decline was greater in those using vest (P = 0.02). Adherence was not significantly different (P = 0.09). Overall treatment satisfaction was higher in vest and FD than in postural drainage (P < 0.05). Health-related quality of life was not different. The rate of FEV(1) decline was 1.23% predicted/year.

conclusionsThe study was ended early due to dropout and smaller than expected decline in FEV(1). Patients were more satisfied with vest and FD. The longitudinal decline in FEF(25-75%) was faster in vest; we found no other difference in lung function decline, taken together this warrants further study. The slow decline in FEV(1) illustrates the difficulty with FEV(1) decline as a clinical trial outcome.

Indexed as

Chest Wall OscillationDrainage, PosturalPatient DropoutsAdolescentChildCystic FibrosisFemaleForced Expiratory VolumeHumansKaplan-Meier EstimateMalePatient SatisfactionQuality of LifeTreatment OutcomeYoung Adult

Identifiers

PMID20146387
PMCPMC4163837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.